Table 1 Summary of cases subjected to chromogenic in situ hybridisation and microarray-based comparative genomic hybridisation
From: Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines
Case | Type | Gradea | ER/PRb | HER2 CISH | HER2 aCGH | TOP2A CISH | TOP2A aCGH | qRT-PCR |
|---|---|---|---|---|---|---|---|---|
A11735P | MIMP | 3 | −ve/−ve | Amp | Amp | Not Amp | Not Amp | Yes |
M13 | IDC | 3 | +ve/−ve | Amp | Amp | Not Ampc | Not Amp | Yes |
M324 | IDC | 3 | +ve/+ve | Amp | Amp | Not Amp | Not Amp | Yes |
M345 | IDC | 3 | +ve/+ve | Amp | Amp | Not Amp | Not Amp | Yes |
M348 | IDC | 3 | −ve/−ve | Amp | Amp | Not Amp | Not Amp | Yes |
M37 | IDC | 3 | +ve/−ve | Amp | Amp | Amp | Amp | Yes |
M61 | P-ILC | 3 | +ve/−ve | Amp | Amp | Amp | Amp | Yes |
M166 | IDC | 3 | +ve/−ve | Amp | Amp | Amp | Amp | Yes |
M168 | IDC | 3 | +ve/+ve | Amp | Amp | Amp | Amp | Yes |
M180 | IDC | 3 | −ve/−ve | Amp | Amp | Amp | Amp | Yes |
M275 | IDC | 3 | +ve/+ve | Amp | Amp | Amp | Amp | Yes |
M300 | IDC | 2 | +ve/+ve | Amp | Amp | Amp | Amp | Yes |
M309 | IDC | 3 | −ve/−ve | Amp | Amp | Amp | Amp | Yes |
M312 | Mixed | 3 | +ve/+ve | Amp | Amp | Amp | Amp | Yes |
X644 | MIMP | 3 | −ve/−ve | Amp | Amp | Amp | Amp | Yes |
M346 | Mixed | 2 | +ve/+ve | Amp | NA | Not Amp | NA | Yes |
M144 | IDC | 3 | −ve/+ve | Amp | NA | Not Amp | NA | Yes |
M347 | IDC | 3 | +ve/+ve | Amp | NA | Not Amp | NA | Yes |
M327 | IDC | 3 | −ve/+ve | Amp | NA | Not Amp | NA | Yes |
M19 | IDC | 3 | +ve/+ve | Amp | NA | Not Amp | NA | Yes |
M230 | IDC | 3 | +ve/+ve | Amp | NA | Not Amp | NA | Yes |
M259 | IDC | 3 | +ve/+ve | Amp | NA | Not Amp | NA | Yes |
M257 | IDC | 3 | −ve/+ve | Amp | NA | Amp | NA | Yes |
M316 | IDC | 3 | +ve/+ve | Amp | NA | Amp | NA | Yes |
M337 | IDC | 2 | +ve/+ve | Amp | NA | Amp | NA | Yes |
M245 | IDC | 3 | +ve/+ve | Amp | NA | Amp | NA | Yes |
M270 | IDC | 2 | −ve/−ve | Amp | NA | Amp | NA | Yes |